These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 15967654
1. MHC multimer technology: current status and future prospects. Bakker AH, Schumacher TN. Curr Opin Immunol; 2005 Aug; 17(4):428-33. PubMed ID: 15967654 [Abstract] [Full Text] [Related]
2. MHC-peptide multimers: tools of choice for detecting and sorting antigen-specific T-cells. Lang F, Bodinier M. Transfusion; 2001 May; 41(5):687-90. PubMed ID: 11346707 [No Abstract] [Full Text] [Related]
3. How the T cell repertoire becomes peptide and MHC specific. Huseby ES, White J, Crawford F, Vass T, Becker D, Pinilla C, Marrack P, Kappler JW. Cell; 2005 Jul 29; 122(2):247-60. PubMed ID: 16051149 [Abstract] [Full Text] [Related]
4. Peptide binding to MHC class I and II proteins: new avenues from new methods. Yaneva R, Schneeweiss C, Zacharias M, Springer S. Mol Immunol; 2010 Jan 29; 47(4):649-57. PubMed ID: 19910050 [Abstract] [Full Text] [Related]
5. Tracking antigen-specific CD8+ T cells in the rat using MHC class I multimers. Duplan V, Suberbielle E, Napper CE, Joly E, Saoudi A, Gonzalez-Dunia D. J Immunol Methods; 2007 Mar 30; 320(1-2):30-9. PubMed ID: 17223126 [Abstract] [Full Text] [Related]
6. Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions. Cecconi V, Moro M, Del Mare S, Dellabona P, Casorati G. Cytometry A; 2008 Nov 30; 73(11):1010-8. PubMed ID: 18612991 [Abstract] [Full Text] [Related]
7. The role of major histocompatibility molecules in antigen-specific immune responses. McCluskey J, Blok R, Kjer-Nielsen L. Transplant Proc; 1989 Feb 30; 21(1 Pt 1):591-4. PubMed ID: 2495622 [No Abstract] [Full Text] [Related]
8. Peptide interactions with class I and II MHC encoded molecules. Pecht I. Isr J Med Sci; 1994 Mar 30; 30(3):28-31. PubMed ID: 7514162 [No Abstract] [Full Text] [Related]
9. Effector and regulatory T cells derived from the same T cell clone differ in MHC class II-peptide multimer binding. Nolte-'t Hoen EN, Amoroso MG, Veenstra J, Grosfeld-Stulemeyer MC, van Eden W, Broeren CP, Wauben MH. Eur J Immunol; 2004 Dec 30; 34(12):3359-69. PubMed ID: 15549773 [Abstract] [Full Text] [Related]
10. The T-cell repertoire for antigen and MHC. Marrack P, Kappler J. Immunol Today; 1988 Oct 30; 9(10):308-15. PubMed ID: 3076400 [No Abstract] [Full Text] [Related]
11. Impact of CD8-MHC class I interaction in detection and sorting efficiencies of antigen-specific T cells using MHC class I/peptide multimers: contribution of pMHC valency. Neveu B, Echasserieau K, Hill T, Kuus-Reichel K, Houssaint E, Bonneville M, Saulquin X. Int Immunol; 2006 Jul 30; 18(7):1139-45. PubMed ID: 16751231 [Abstract] [Full Text] [Related]
12. MHC class I antigen presentation--recently trimmed and well presented. Flutter B, Gao B. Cell Mol Immunol; 2004 Feb 30; 1(1):22-30. PubMed ID: 16212917 [Abstract] [Full Text] [Related]
13. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines. Dobaño C, Rogers WO, Gowda K, Doolan DL. Immunol Lett; 2007 Aug 15; 111(2):92-102. PubMed ID: 17604849 [Abstract] [Full Text] [Related]
14. Interpreting MHC class I expression and class I/class II reciprocity in the CNS: reconciling divergent findings. Lampson LA. Microsc Res Tech; 1995 Nov 01; 32(4):267-85. PubMed ID: 8573777 [Abstract] [Full Text] [Related]
15. CD4+ T helper cell response is required for memory in CD8+ T lymphocytes induced by a poly(I:C)-adjuvanted MHC I-restricted peptide epitope. Qiu F, Cui Z. J Immunother; 2007 Nov 01; 30(2):180-9. PubMed ID: 17471165 [Abstract] [Full Text] [Related]
16. Construction of MHC class I-peptide tetrameric complexes for analysis of T-cell-mediated immune responses. Samuel RV, Hanke T. Methods Mol Med; 2003 Nov 01; 87():279-88. PubMed ID: 12958462 [No Abstract] [Full Text] [Related]
17. Journey beyond immunology. Regulation of receptor internalization by major histocompatibility complex class I (MHC-I) and effect of peptides derived from MHC-I. Stagsted J. APMIS Suppl; 1998 Nov 01; 85():1-40. PubMed ID: 9849573 [No Abstract] [Full Text] [Related]
18. Identification of natural MHC class II presented phosphopeptides and tumor-derived MHC class I phospholigands. Meyer VS, Drews O, Günder M, Hennenlotter J, Rammensee HG, Stevanovic S. J Proteome Res; 2009 Jul 01; 8(7):3666-74. PubMed ID: 19415920 [Abstract] [Full Text] [Related]
19. Peptide binding motifs for MHC class I and II molecules. Biddison WE, Martin R. Curr Protoc Immunol; 2001 May 01; Appendix 1():Appendix 1I. PubMed ID: 18432645 [Abstract] [Full Text] [Related]
20. Exogenous antigen control of autoreactive T-cell MHC specificity. DosReis GA. Immunol Today; 1994 Dec 01; 15(12):597-8. PubMed ID: 7531448 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]